Clinical Trial Update: Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating azacitidine plus phenylbutyrate for acute myeloid leukemia or myelodysplastic syndromes has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Myeloproliferative Diseases
• Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Phenylbutyrate (phenylbutyrate)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: COMPLETED